Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials
The serine/threonine kinase Akt is a major player in the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway, and its modulation impacts multiple cellular processes such as growth, proliferation, and survival. Several abnormalities in this pathway have been do...
Saved in:
Main Authors: | Bruno Toson (Author), Isadora S. Fortes (Author), Rafael Roesler (Author), Saulo F. Andrade (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells
by: Coffer PJ, et al.
Published: (2011) -
Loss of PKBβ/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo
by: David F. Restuccia, et al.
Published: (2012) -
The Development of Sustainable Profession (PKB) of Teachers in Senior High School
by: Tibyan Ravaie, et al.
Published: (2018) -
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
by: Austin Lui, et al.
Published: (2024) -
Blocking Epidermal Growth Factor Receptor Signaling in HTR-8/SVneo First Trimester Trophoblast Cells Results in Dephosphorylation of PKBα/AKT and Induces Apoptosis
by: J. Bolnick, et al.
Published: (2011)